|
 |
Investigational Drug for Ischemic Stroke
(Source: Neurobiological Technologies) " Neurobiological Technologies announced new analysis of data from clinical trials of their investigational drug, Viprinex™(ancrod) and updates on the clinical development of the drug for the treatment of acute ischemic stroke. The information was presented at the American Stroke Associations' 2007 International Stroke Conference.
"Give It to Me Straight, Doc"
(Source: Business Wire) - A new national survey reveals that, surprisingly, many Americans don't just want to know about the good things that the future holds; yet they do want to know about diseases they are at risk of getting "even those for which there are no cures."
Drivers with Dementia is Topic of Health Providers Workshop
Researchers at the Alzheimer's Disease Research Center School of Medicine and colleagues have developed a three-hour workshop that trains health-care providers to identify potentially unsafe drivers with dementia and to encourage appropriate retirement from driving.
UK DoH Leader Contradicts' NICE on Alzheimer's Care
(Source: Healthcare Republic) - According to the United Kingdom Department of Health (DoH) Professor Ian Philp endorses early intervention for dementia because it, "Has been shown to help sufferers and their families enjoy a higher quality of life and reduce the need for admission to care homes."
Pakistan's Alzheimer's Patients Will Be Provided Assistance
(Source: Daily Times) - Speaking at the inauguration of Pakistan's first day-care center, Health Minister Chaudhry Muhammad Iqbal on Thursday said that the Health Department was allocating resources for the treatment and rehabilitation of people suffering from psychological and dementia complications.
Elderly Married Couples Don't Let Nursing Homes Keep Them Apart
(Source: University of Alberta) - According to a new study from the University of Alberta, seniors work hard to keep their marriages alive and well, even after one spouse falls ill and goes into a long-term care facility.
Tolerability of Different Dose Levels of Memantine
(Source: Doc Guide) - The Research Institute for the Care of the Elderly (Bath, UK) conducted a study to assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease. The results indicated that once-daily dosing and twice-daily dosing are similar in terms of safety and tolerability.
Memantine for Mild-to-Moderate Alzheimer's Disease
(Source: Doc Guide) - Memantine is the first and only medication that has been approved by European, US and Canadian regulatory agencies for the treatment of moderate-to-severe Alzheimer's disease.
Clock Drawing and Frontal Lobe Behavioral Effects of Memantine
(Source: Doc Guide) - Caregivers of Alzheimer's patients treated with memantine have reported improved frontal lobe behaviors. A University of Massachusetts Medical School study examined possible improvements in executive functioning using a clock-drawing test.
From MCI to Alzheimer's Disease
(Source: Doc Guide) - Researchers at the Medical University Vienna, Austria, report results of a study indicating that patients with mild cognitive impairment (MCI) showed a high probability to be diagnosed with Alzheimer dementia after 30 months.
President Proposes to Cut Alzheimer Research and Care
LETTERS TO THE EDITOR
On February 5th President Bush sent his 2008 budget proposal to Congress. Once again, the President proposes to cut federal funding for Alzheimer research and care. Under the President's proposal, funding for Alzheimer research continues a negative trend - a steady decline since 2003. The President's budget proposal also eliminates funding for key Alzheimer's care programs, including the 24/7 Contact Center, Safe Return® and the Alzheimer's State Matching Grants Program.
If Everyone Gave Just $1
Letter to the Editor
I firmly believe that all that is needed to defeat Alzheimer's disease is a dedicated, team effort.
Mr. Bush, Mr. Cheney, Congress " What Are You Thinking?
Letter to the Editor
We should all be outraged with the behavior of all the members of the last Congress. They met for a year and couldn't (I would argue wouldn't) produce a budget! The nation's domestic needs will end this year with only last year's appropriation levels, plus a few extra bucks. In other words, they decided just to give themselves a pass on the budget this year.
|
|